Adaptimmune Therapeutics Correlations

ADAP Stock  USD 0.22  0.01  4.35%   
The current 90-days correlation between Adaptimmune Therapeutics and Black Diamond Therapeutics is -0.1 (i.e., Good diversification). The correlation of Adaptimmune Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.

Adaptimmune Therapeutics Correlation With Market

Average diversification

The correlation between Adaptimmune Therapeutics Plc and DJI is 0.14 (i.e., Average diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Adaptimmune Therapeutics Plc and DJI in the same portfolio, assuming nothing else is changed.
  
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Adaptimmune Therapeutics Plc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

Moving together with Adaptimmune Stock

  0.76CDIOW Cardio DiagnosticsPairCorr
  0.69SCLX Scilex HoldingPairCorr
  0.73ASMB Assembly BiosciencesPairCorr
  0.68CMND Clearmind Medicine CommonPairCorr
  0.71HD Home DepotPairCorr
  0.77DIS Walt DisneyPairCorr
  0.65MSFT MicrosoftPairCorr

Moving against Adaptimmune Stock

  0.62LUCD Lucid DiagnosticsPairCorr
  0.49WM Waste ManagementPairCorr
  0.41GE GE AerospacePairCorr
  0.76XOM Exxon Mobil Corp Earnings Call This WeekPairCorr
  0.65JNJ Johnson JohnsonPairCorr
  0.65T ATT Inc Aggressive PushPairCorr
  0.65CVX Chevron CorpPairCorr
  0.47INTC IntelPairCorr
  0.45MMM 3M CompanyPairCorr
  0.34IBM International BusinessPairCorr

Related Correlations Analysis

Click cells to compare fundamentals   Check Volatility   Backtest Portfolio

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.
High positive correlations   
AFMDMREO
AFMDLPTX
PDSBMREO
LPTXMREO
CRVSMREO
PDSBSTOK
  
High negative correlations   
CRVSPIRS
AFMDPIRS
LPTXPIRS
PDSBPIRS
PIRSMREO
CRVSHARP

Risk-Adjusted Indicators

There is a big difference between Adaptimmune Stock performing well and Adaptimmune Therapeutics Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Adaptimmune Therapeutics' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
Mean DeviationJensen AlphaSortino RatioTreynor RatioSemi DeviationExpected ShortfallPotential UpsideValue @RiskMaximum Drawdown
STOK  3.48 (0.51) 0.00 (0.29) 0.00 
 7.03 
 20.29 
FIXX  0.00  0.00  0.00  0.00  0.00 
 0.00 
 0.00 
BDTX  3.90 (0.46) 0.00 (0.24) 0.00 
 7.09 
 29.04 
HARP  0.00  0.00  0.00  0.00  0.00 
 0.00 
 0.00 
MREO  2.68 (0.44) 0.00 (0.54) 0.00 
 6.16 
 20.77 
PIRS  0.00  0.00  0.00  0.00  0.00 
 0.00 
 0.00 
PDSB  4.46 (0.40) 0.00 (0.40) 0.00 
 9.21 
 33.91 
LPTX  4.79 (1.88) 0.00 (5.23) 0.00 
 5.88 
 82.92 
AFMD  2.56 (0.58) 0.00 (1.23) 0.00 
 5.10 
 23.29 
CRVS  3.65 (0.42) 0.00 (0.37) 0.00 
 7.37 
 17.12 

Adaptimmune Therapeutics Corporate Management

Kerry SharpSenior CouncilProfile
Dennis WilliamsSenior DevelopmentProfile
Sbastien DesprezVP AffairsProfile
Dana LynchSenior CommunicationsProfile
Helen MBACoFounder OfficerProfile
Bertrand EsqChief OfficerProfile